Velocity Clinical Research Appoints Dr. Rachael Buck As U.K. Country Head

Velocity Clinical Research, a leading player in the multi-specialty clinical site industry, has announced the appointment of Dr. Rachael Buck as the new Country Head for the U.K. Dr. Buck will oversee the operations of the five Velocity sites currently established in the U.K. and collaborate with the European executive team to enhance the company’s presence in the region.

Dr. Buck brings over two decades of industry experience to her new role, having previously held the position of Senior Director of Site Networks at Accellacare (ICON). Her extensive background includes significant roles at Synexus (AES), Medinova, and Parexel, where she contributed to the growth and success of dedicated research site networks.

In her previous role, Dr. Buck managed global quality assurance, project management, and several other critical functions. Her experience in expanding site networks and forging key partnerships is expected to play a pivotal role in Velocity's continued growth in the U.K. and beyond.

Dominic Clavell, Executive Vice President Europe at Velocity, said in a statement, “Velocity is proud to welcome Rachael as our new Country Manager, a testament to our commitment to attracting top talent from leading organizations in the clinical trials industry. We’re doing things differently at Velocity, changing the way the industry thinks about clinical research and streamlining the approach so that trials get done quicker.”

He further added, “Rachael’s expertise will be instrumental in realizing our vision of creating a cohesive network of high-performing clinical trial sites across Europe. Her leadership will significantly enhance our efforts to scale operations in what has traditionally been a fragmented landscape.”